148 related articles for article (PubMed ID: 28761665)
1. Efficacy of recombinant bovine epidermal growth factor in the treatment of experimental subclinical
Gabadage K; Chirino-Trejo M; Campbell J; Luby C
Vet Rec Open; 2017; 4(1):e000179. PubMed ID: 28761665
[No Abstract] [Full Text] [Related]
2. Effect of prepartum intramammary treatment with pirlimycin hydrochloride on prevalence of early first-lactation mastitis in dairy heifers.
Middleton JR; Timms LL; Bader GR; Lakritz J; Luby CD; Steevens BJ
J Am Vet Med Assoc; 2005 Dec; 227(12):1969-74. PubMed ID: 16379636
[TBL] [Abstract][Full Text] [Related]
3. A comparative randomized field trial on intramammary and intramuscular dry cow antibiotic treatment of subclinical Staphylococcus aureus mastitis in dairy cows.
Shpigel NY; Kass PH; Saran A
J Vet Med A Physiol Pathol Clin Med; 2006 Oct; 53(8):418-22. PubMed ID: 16970632
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of extended pirlimycin therapy for treatment of experimentally induced Streptococcus uberis intramammary infections in lactating dairy cattle.
Oliver SP; Almeida RA; Gillespie BE; Ivey SJ; Moorehead H; Lunn P; Dowlen HH; Johnson DL; Lamar KC
Vet Ther; 2003; 4(3):299-308. PubMed ID: 15136992
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows.
Oliver SP; Gillespie BE; Headrick SJ; Moorehead H; Lunn P; Dowlen HH; Johnson DL; Lamar KC; Chester ST; Moseley WM
J Dairy Sci; 2004 Aug; 87(8):2393-400. PubMed ID: 15328260
[TBL] [Abstract][Full Text] [Related]
6. Early-lactation extended pirlimycin therapy against naturally acquired Staphylococcus aureus intramammary infections in heifers: A randomized controlled trial.
Skoulikas S; Dufour S; Haine D; Perreault JY; Roy JP
J Dairy Sci; 2018 Feb; 101(2):1419-1427. PubMed ID: 29224881
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows.
Gillespie BE; Moorehead H; Lunn P; Dowlen HH; Johnson DL; Lamar KC; Lewis MJ; Ivey SJ; Hallberg JW; Chester ST; Oliver SP
Vet Ther; 2002; 3(4):373-80. PubMed ID: 12584673
[TBL] [Abstract][Full Text] [Related]
8. Relationship between results of in vitro susceptibility tests and outcomes following treatment with pirlimycin hydrochloride in cows with subclinical mastitis associated with gram-positive pathogens.
Apparao D; Oliveira L; Ruegg PL
J Am Vet Med Assoc; 2009 Jun; 234(11):1437-46. PubMed ID: 19480625
[TBL] [Abstract][Full Text] [Related]
9. Subclinical mastitis in pastoralist dairy camel herds in Isiolo, Kenya: Prevalence, risk factors, and antimicrobial susceptibility.
Seligsohn D; Nyman AK; Younan M; Sake W; Persson Y; Bornstein S; Maichomo M; de Verdier K; Morrell JM; Chenais E
J Dairy Sci; 2020 May; 103(5):4717-4731. PubMed ID: 32171518
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle.
Gill JJ; Pacan JC; Carson ME; Leslie KE; Griffiths MW; Sabour PM
Antimicrob Agents Chemother; 2006 Sep; 50(9):2912-8. PubMed ID: 16940081
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows.
Deluyker HA; Van Oye SN; Boucher JF
J Dairy Sci; 2005 Feb; 88(2):604-14. PubMed ID: 15653527
[TBL] [Abstract][Full Text] [Related]
12. Pathogen-specific responses in the bovine udder. Models and immunoprophylactic concepts.
Petzl W; Zerbe H; Günther J; Seyfert HM; Hussen J; Schuberth HJ
Res Vet Sci; 2018 Feb; 116():55-61. PubMed ID: 29275905
[TBL] [Abstract][Full Text] [Related]
13. Udder health in Canadian dairy heifers during early lactation.
Naqvi SA; De Buck J; Dufour S; Barkema HW
J Dairy Sci; 2018 Apr; 101(4):3233-3247. PubMed ID: 29397171
[TBL] [Abstract][Full Text] [Related]
14. Bioeconomic modeling of lactational antimicrobial treatment of new bovine subclinical intramammary infections caused by contagious pathogens.
van den Borne BH; Halasa T; van Schaik G; Hogeveen H; Nielen M
J Dairy Sci; 2010 Sep; 93(9):4034-44. PubMed ID: 20723677
[TBL] [Abstract][Full Text] [Related]
15. Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis.
Barkema HW; Schukken YH; Zadoks RN
J Dairy Sci; 2006 Jun; 89(6):1877-95. PubMed ID: 16702252
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of extended cefquinome treatment of clinical Staphylococcus aureus mastitis.
Swinkels JM; Cox P; Schukken YH; Lam TJ
J Dairy Sci; 2013 Aug; 96(8):4983-92. PubMed ID: 23706485
[TBL] [Abstract][Full Text] [Related]
17. Distribution of non-aureus staphylococci species in udder quarters with low and high somatic cell count, and clinical mastitis.
Condas LAZ; De Buck J; Nobrega DB; Carson DA; Roy JP; Keefe GP; DeVries TJ; Middleton JR; Dufour S; Barkema HW
J Dairy Sci; 2017 Jul; 100(7):5613-5627. PubMed ID: 28456402
[TBL] [Abstract][Full Text] [Related]
18. Pathogen group specific risk factors for clinical mastitis, intramammary infection and blind quarters at the herd, cow and quarter level in smallholder dairy farms in Jimma, Ethiopia.
Tolosa T; Verbeke J; Ayana Z; Piepers S; Supré K; De Vliegher S
Prev Vet Med; 2015 Jul; 120(3-4):306-12. PubMed ID: 26008577
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of somatic cell count patterns as a proxy for transmission of mastitis pathogens.
Dalen G; Rachah A; Nørstebø H; Schukken YH; Reksen O
J Dairy Sci; 2019 Dec; 102(12):11349-11358. PubMed ID: 31563313
[TBL] [Abstract][Full Text] [Related]
20. Intramammary infections with different non-aureus staphylococci in dairy cows.
Nyman AK; Fasth C; Waller KP
J Dairy Sci; 2018 Feb; 101(2):1403-1418. PubMed ID: 29174143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
